Maximus, Inc. $MMS Stock Holdings Lifted by WINTON GROUP Ltd

WINTON GROUP Ltd increased its position in shares of Maximus, Inc. (NYSE:MMS) by 1,992.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,687 shares of the health services provider’s stock after acquiring an additional 79,687 shares during the quarter. WINTON GROUP Ltd’s holdings in Maximus were worth $4,499,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Parkside Financial Bank & Trust boosted its stake in Maximus by 13.4% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider’s stock worth $109,000 after purchasing an additional 150 shares during the period. Blue Trust Inc. raised its stake in Maximus by 14.6% during the 1st quarter. Blue Trust Inc. now owns 1,321 shares of the health services provider’s stock valued at $85,000 after purchasing an additional 168 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Maximus by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after purchasing an additional 221 shares during the period. Larson Financial Group LLC lifted its holdings in shares of Maximus by 13.8% in the third quarter. Larson Financial Group LLC now owns 1,869 shares of the health services provider’s stock valued at $171,000 after purchasing an additional 227 shares in the last quarter. Finally, QRG Capital Management Inc. lifted its holdings in shares of Maximus by 9.3% in the first quarter. QRG Capital Management Inc. now owns 3,240 shares of the health services provider’s stock valued at $208,000 after purchasing an additional 277 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Stock Up 0.8%

MMS stock opened at $56.58 on Friday. Maximus, Inc. has a 12-month low of $52.73 and a 12-month high of $100.00. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. The company has a market cap of $2.96 billion, a price-to-earnings ratio of 8.36 and a beta of 0.59. The company has a 50 day moving average of $58.09 and a two-hundred day moving average of $62.43.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the business posted $2.16 EPS. The company’s revenue for the quarter was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, equities analysts anticipate that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a yield of 2.3%. Maximus’s dividend payout ratio (DPR) is presently 19.50%.

Analyst Ratings Changes

MMS has been the subject of several recent analyst reports. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Zacks Research lowered Maximus from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 11th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.